US 12384845
Activatable masked anti-CTLA4 binding proteins
granted A61KA61K2039/505A61K47/6849
Quick answer
US patent 12384845 (Activatable masked anti-CTLA4 binding proteins) held by Xilio Development, Inc. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xilio Development, Inc.
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K47/6849, A61P, A61P35/00